• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Carcinoma, Verrucous

Carcinoma, Verrucous - 20 Studies Found

Completed : Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
:
  • Lip and Oral Cavity Squamous Cell Carcinoma
  • Oral Cavity Verrucous Carc
    : 2011-08-09
    :
    • Drug: vandetanib Given PO

Completed : Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery
:
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
    : 2013-12-04
    :
    • Other: Laboratory Biomarker Analysis

Terminated : Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer
:
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Verruc
    : 2014-02-18
    :
    • Other: Laboratory Biomarker Analysis

Withdrawn : Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity
:
  • Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
  • Recurrent Squamous Cell Carcino
    : 2014-04-17
    :
    • Drug: HPPH Undergo photodynami

Recruiting : Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
:
  • Head and Neck Squamous Cell Carcinoma
  • Laryngeal Squamous Cell Carcinoma, Spindle Cell Varian
    : 2016-04-06
    :
    • Drug: Cisplatin Given IV

Completed : Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care
:
  • Lip and Oral Cavity Squamous Cell Carcinoma
  • Oral Cavity Verrucous Carc
    : 2013-03-20
    :
    • Procedure: fluorescence imaging

Completed : Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity
:
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • Stage III : 2014-11-17
    :
    • Radiation: hypofractionated radiation therapy

Terminated : Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
:
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
    : 2014-07-18
    :
    • Drug: Cisplatin Given IV

Withdrawn : Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer
:
  • Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
  • Recurrent Squamous Cell Carcino
    : 2012-10-29
    :
    • Drug: photodynamic therapy Und

Terminated : Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
:
  • Salivary Gland Squamous Cell Carcinoma
  • Stage II Salivary Gland Cancer
  • Radiation: intensity-modulated radiation therapy

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.